<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="award001">
  <funding-source>
   <institution>AFHSB-GEIS</institution>
  </funding-source>
  <award-id>W911QY-16-C-0160</award-id>
  <principal-award-recipient>
   <name>
    <surname>Linton</surname>
    <given-names>Yvonne-Marie</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award002">
  <funding-source>
   <institution>AIM-COST</institution>
  </funding-source>
  <principal-award-recipient>
   <name>
    <surname>Günay</surname>
    <given-names>Filiz</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award003">
  <funding-source>
   <institution>AIM-COST</institution>
  </funding-source>
  <principal-award-recipient>
   <name>
    <surname>Alten</surname>
    <given-names>Bülent</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <funding-statement>This study was supported in part by the Armed Forces Health Surveillance Board, Global Emerging Infections Surveillance and Response System (AFHSB-GEIS), United States of America (FY18 award P0034_18_WR (PI: Yvonne-Marie Linton) under US Army subcontract W911QY-16-C-0160). BA and FG were also included in AIM-COST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The material to be published reflects the views of the authors and should not be construed to represent those of the US Department of the Army or the US Department of Defense.</funding-statement>
</funding-group>
